Cognition Therapeutics Inc (CGTX) stock saw a modest uptick, ending the day at $0.65 which represents a slight increase of $0.04 or 6.56% from the prior close of $0.61. The stock opened at $0.61 and ...

Fintel reports that on December 19, 2024, B. Riley Securities upgraded their outlook for Cognition Therapeutics ...

On Friday, Cognition Therapeutics Inc (CGTX) stock saw a modest uptick, ending the day at $0.63 which represents no change from the prior close of of $0.63. The stock opened at $0.64 and touched a low ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The price trend for Cognition Therapeutics, Inc. (CGTX) has been bearish lately and the stock has lost 9.6% over the past week. However, the formation of a hammer chart pattern in its last trading ...

Fintel reports that on December 19, 2024, B. Riley Securities upgraded their outlook for Cognition Therapeutics (NasdaqGM:CGTX) from Neutral to Buy. As of December 3, 2024, the average one-year ...

On Thursday, H.C. Wainwright adjusted its stock price target for Cognition Therapeutics (NASDAQ:CGTX), a company focused on developing drugs for neurodegenerative disorders. The firm increased the ...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new ...

The price trend for Cognition Therapeutics, Inc. (CGTX) has been bearish lately and the stock has lost 9.6% over the past week. However, the formation of a hammer chart pattern in its last trading ...

On Thursday, H.C. Wainwright adjusted its stock price target for Cognition Therapeutics (NASDAQ:CGTX), a company focused on developing drugs for neurodegenerative disorders. The firm increased the ...